دورية أكاديمية
Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
العنوان: | Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents |
---|---|
المؤلفون: | Hae Won Yoo, Jun Yong Park, Sang Gyune Kim, Young Kul Jung, Sae Hwan Lee, Moon Young Kim, Dae Won Jun, Jae Young Jang, Jin Woo Lee, Oh Sang Kwon |
المصدر: | Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022) |
بيانات النشر: | Nature Portfolio, 2022. |
سنة النشر: | 2022 |
المجموعة: | LCC:Medicine LCC:Science |
مصطلحات موضوعية: | Medicine, Science |
الوصف: | Abstract We prospectively investigated the changes of liver stiffness (LS) and the occurrence of hepatocellular carcinoma (HCC) after hepatitis C virus (HCV) eradication using direct antiviral agents (DAA) over three years. LS measurement using transient elastography and serum fibrosis surrogate markers before treatment and at 48, 96, 144 weeks after starting direct-acting antivirals (DAA) according to the protocol were evaluated. Patients were also compared with historical cohort treated with pegylated interferon (peg-IFN). Sustained viral response (SVR) was observed in 95.8%. LS value in the patients achieving SVR significantly decreased over time (19.4 ± 12.9 kPa [baseline], 13.9 ± 9.1 kPa [48 weeks], 11.7 ± 8.2 kPa [96 weeks], 10.09 ± 6.23 [144 weeks], all p |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2045-2322 |
Relation: | https://doaj.org/toc/2045-2322 |
DOI: | 10.1038/s41598-021-03272-1 |
URL الوصول: | https://doaj.org/article/2a378d125ae0426091933efb03db7a36 |
رقم الأكسشن: | edsdoj.2a378d125ae0426091933efb03db7a36 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 20452322 |
---|---|
DOI: | 10.1038/s41598-021-03272-1 |